Category: Biotech
-
![Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)]()
Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)
Dr. Mario Saltarelli, Director of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical…
-
![Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q]()
Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been a busy week for Cybin. Last week, after market close, they released their financials for the quarter ending on June 30, 2021, which showed they had…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
![Filament Health (FH.NE): the natural psychedelic company flying under the radar]()
Filament Health (FH.NE): the natural psychedelic company flying under the radar
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…
-
![Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery]()
Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery
Jody Vance, well-known Vancouver-based talk show personality talks with Jeremy Sobotta, Perimeter Medical Imaging (PINK.C) CEO, to get a good look at the company’s mandate of improving the effectiveness of breast cancer surgery by getting everything the first time and how that will impact cancer treatment. We take a look at the technology, the company,…
-
![Valeo Pharma(VPH), complicated sector but simple business model]()
Valeo Pharma(VPH), complicated sector but simple business model
Stock Performance From the chart below it seemed like the Valeo Pharma (“VPH”) shareholders have had quite a wild ride over the last few years. Starting in 2019 the stock was trading at $0.72 per share, but by mid-August, the stock had dropped by almost 50% to around $0.30 per share before it did nothing…
-
![Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance]()
Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand for this financing was very strong and we are thankful for the outstanding work of our banking syndicate partners and advisors and we welcome all new…
-
![Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering]()
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Cybin (CYBN.NE) announced that they have received final approval from the New York Stock Exchange (NYSE) to list its shares on the NYSE American exchange. Beginning next Thursday, on August 5, 2021, Cybin will begin trading on the NYSE American under the ticker “CYBN”. Cybin will continue to trade on the NEO exchange, also under…
-
![Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates]()
Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates
On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection. Xphyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. 3a-diagnostics is currently a commercial partner of…
-
Cybin (CYBN.NEO): Grown up approach to psychedelics brings half billion valuation… so far
Back in January of this year, we told you about a psychedelics company that was going to come at that sector like many had talked about, but few had achieved. Their angle? Be a biotech company. Don’t dick about with fakey business plans or black velvet paintings of Elvis. No Jamaican B&Bs dressed up as…
